P3 Health Partners Q2 EPS $(0.09) Beats $(0.24) Estimate, Sales $329.09M Beat $303.30M Estimate
Portfolio Pulse from Benzinga Newsdesk
P3 Health Partners (NASDAQ:PIII) reported Q2 EPS of $(0.09), beating the estimate of $(0.24) by 62.5%. This is a 97.59% increase over losses from the same period last year. The company also reported quarterly sales of $329.09M, beating the estimate of $303.30M by 8.50%. This is a 22.13% increase over sales from the same period last year.
August 07, 2023 | 8:10 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
P3 Health Partners reported better than expected Q2 earnings and sales, indicating a strong financial performance.
P3 Health Partners reported a Q2 EPS of $(0.09), beating the estimate of $(0.24) by 62.5%. This is a significant improvement over the same period last year. Additionally, the company's sales of $329.09M beat the estimate of $303.30M by 8.50%. These positive financial results indicate a strong performance and could potentially lead to a short-term increase in the company's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100